Document is current
Any future updates will be listed below
-
Authors
Vincenzi, Elena
Buccardi, Martina
Ferrini, Erica
Fantazzini, Alice
Polverini, Eugenia
Villetti, Gino
Sverzellati, Nicola
Aliverti, Andrea
Basso, Curzio
Pennati, Francesca
Stellari, Franco Fabio https://orcid.org/0000-0002-8855-7297
-
Funding
Funding for this research was provided by:
Chiesi Farmaceutici
AdvaNced Technologies for Human-centrEd Medicine (PNC0000003)
- License Information
-
More Information
Article History
Received: 27 August 2024
Accepted: 31 October 2024
First Online: 18 November 2024
Declarations
:
: All animal experiments described herein were authorized by the official competent authority and approved by the intramural animal-welfare body (AWB) of Chiesi Farmaceutici and authorized by the Italian Ministry of Health (protocol number: 449/2016-PR). All procedures were conducted in compliance with the European Directive 2010/63 UE, Italian D.Lgs 26/2014, the revised “Guide for the Care and Use of Laboratory Animals” and with the ‘Animal Research: Reporting of In Vivo Experiments’ (ARRIVE) guidelines.
: Not applicable.
: FFS, GV and EF are employees of Chiesi Farmaceutici S.p.A., which supported the research work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.
